News Conference News AHA 2021 ApoB Gains Ground as Best Lipid Predictor of MI Risk Michael O'Riordan November 22, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Daily News Cumulative Burden of LDL Cholesterol Increases CHD Risk Michael O'Riordan September 23, 2021
News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Daily News Less Cancer Among HF Patients Taking Statins, Registry Shows Michael O'Riordan June 23, 2021
News Daily News Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors Michael O'Riordan June 16, 2021
News Conference News AHA 2020 OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients Todd Neale November 15, 2020
News Conference News AHA 2020 Fish Oil Tanks in STRENGTH, Making Waves for REDUCE-IT Todd Neale November 15, 2020
News Conference News AHA 2020 One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3 Michael O'Riordan November 13, 2020
News Conference News AHA 2020 Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol Michael O'Riordan November 12, 2020
News Conference News TCT 2020 Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT Todd Neale October 21, 2020
News Daily News LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes Yael L. Maxwell September 14, 2020
News Daily News Could Statins Curb Fatal or Severe COVID-19? Some Clues Michael O'Riordan August 14, 2020
News Daily News Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes Michael O'Riordan January 14, 2020
News Daily News AHA Plugs ‘Dietary Patterns’ Over Dietary Cholesterol Targets Yael L. Maxwell December 26, 2019
News Daily News Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk Michael O'Riordan December 03, 2019